Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News TREATWolfram clinical trial to unlock a potential treatment for a rare disease Birmingham is making a real-world impact on rare diseases, with a comprehensive multi-facility network for research helping to find new treatments for patients like those with Wolfram syndrome.
News Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse
News Cancer Research UK Clinical Trials Unit: Celebrating 40 Years of Funding From Cancer Research UK
11 November 2022 Rare cancer treatment changed thanks to major clinical trial Children and adult with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a CRCTU clinical trial.
27 October 2022 How chameleon cancers can change their colors to survive treatment Some leukemias evade treatment by changing their appearance and identity through changing the read-out of their DNA, a new study has found.
18 October 2022 AI takes guesswork out of lateral flow testing A new trial found that an AI app-based reader for lateral flow devices reduced false Covid negatives in assisted test sites.
14 October 2022 New £30M research injection to improve treatment of inflammatory diseases Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
20 September 2022 Research identifies new treatment target for CNS injury and neurological disease Potential target could treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.
12 July 2022 Research shows investigational drug fosters nerve repair after injury Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug can foster regeneration of damaged nerves after spinal trauma